Panel Discussion | What Have We Learned from the Past 30 Years on the Pathophysiology of Cardiogenic Shock

Sunday, March 9, 2025

9:04 AM - 9:38 AM ET

Panel Moderator(s)

Mitchell Krucoff, MD, FACC, FAHA, FSCAI

Professor Medicine/Cardiology
Duke University Medical Center/Duke Clinical Research Institute
Durham, North Carolina, United States

No relationships to disclose
Mohit Pahuja, MD

Assistant Professor of Medicine, Division of Interventional and advanced heart failure cardiology
University of Oklahoma Medical Center
Nichols Hills, Oklahoma, United States

No relationships to disclose

Panel Discussant(s)

Daniel Burkhoff, MD, PhD

Director: Heart Failure, Hemodynamics and MCS Research
Cardiovascular Research Foundation
New York, New York, United States

No relationships to disclose
Rafael Cavalcante, MD, PhD

Vice President, Medical Affairs
Boston Scientific
Newton, Massachusetts, United States

No relationships to disclose
Lindsey Cilia, MD

Co-Director of Complex Coronary Therapeutics Program Interventional Cardiologist
Inova Heart and Vascular Institute/Virginia Heart
Falls Church, Virginia, United States

No relationships to disclose
Navin K. Kapur, MD, FSCAI FAHA FACC

Professor of Medicine
Tufts Medical Center
Boston, Massachusetts, United States

Disclosure information not submitted.
Alexandra J. Lansky, MD, FACC, FAHA, MSCAI, FESC

Professor of Medicine
Yale School of Medicine
New Haven, Connecticut, United States

No relationships to disclose
Michael J. Rinaldi, MD

Director Structural Heart Program
Sanger Heart and Vascular Institute/Atrium Health
Charlotte, North Carolina, United States

Disclosure information not submitted.
Shashank S. Sinha, MD, MSc

Director, Cardiac ICU; Director, Cardiovascular Critical Care Research
Inova Schar Heart and Vascular / Inova Fairfax Medical Campus
Fairfax, Virginia, United States

No relationships to disclose

Disclosure(s):

Mitchell Krucoff, MD, FACC, FAHA, FSCAI: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consultant (Ongoing); Cook medical: Consultant (Ongoing); Getinge: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); InfraRedx: Consultant (Ongoing); Johnson & Johnson: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); OrbusNeich Medical Inc.: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Mohit Pahuja, MD: No financial relationships to disclose

Daniel Burkhoff, MD, PhD: No financial relationships to disclose

Lindsey Cilia, MD: No financial relationships to disclose

Navin K. Kapur, MD, FSCAI FAHA FACC: Getinge: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Alexandra J. Lansky, MD, FACC, FAHA, MSCAI, FESC: No financial relationships to disclose

Michael J. Rinaldi, MD: Abbott Vascular,: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); abiomed: Consultant (Ongoing); boston scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); edwards: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); shockwave: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Shashank S. Sinha, MD, MSc: No financial relationships to disclose